Géraldine S.
- Country
- France
- Department
- hématologie
Research Overview
Data & Insights
Has run more than one trial at 0 of 23 partner sites.
Specializations
Hematologic Oncology
This investigator specializes in treating chronic phase chronic myelogenous leukemia (CP-CML), with particular focus on developing innovative therapeutic approaches for patients who achieve complete cytogenetic response but lack deep molecular response.
- Leukemia Management
- Molecular Response Assessment
- Combination Therapy Strategies
The investigator explores various therapeutic combinations involving tyrosine kinase inhibitors for enhanced treatment outcomes in hematologic malignancies.
Targeted Therapies
Research interests center on optimizing treatment with various targeted therapeutic agents, including imatinib, nilotinib, dasatinib, and bosutinib in hematologic conditions.
- Treatment Optimization
- Drug Combinations
- Sequential Therapy
The investigator focuses on developing adaptive treatment strategies to improve therapeutic outcomes in resistant or suboptimal responding patients.
Treatment Innovation
Expertise includes implementing adaptive trial designs to evaluate novel therapeutic approaches in hematologic oncology.
- Clinical Trial Design
- Response Assessment
- Treatment Selection
The investigator utilizes innovative methodologies to assess treatment efficacy and molecular response in blood cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.